Abstract. The mechanism underlying OSCC tumorigenesis remains unclear. Periostin is considered to be a prominent oncogene in various solid tumors, although its precise role in OSCC progression remains unknown. In the present study, periostin expression was examined in surgical specimens of OSCC cases, and the results were analyzed for possible correlations with clinical characteristics. In addition, the proliferation and invasiveness of OSCC cells were evaluated following transfection with a Periostin small interfering RNA or an overexpression plasmid. The results revealed that periostin levels were significantly higher in patients with OSCC as compared with those in the controls (P<0.05). In addition, periostin levels in patients with OSCC were significantly associated with permeation classification. Furthermore, periostin expression was observed to promote the proliferation and invasiveness of OSCC cells. The present results suggest that periostin is significantly involved in the pathogenesis of OSCC.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is one of the most prevalent cancers and a major cause of mortality in patients with cancer worldwide, and 330,000 mortality cases are reported each year as a result of this disease (1) . Approximately half of these cases involve oral squamous cell carcinoma (OSCC) (2) , which is a highly aggressive head and neck tumor prone to local recurrence and metastasis (3) . The development of OSCC is a long-term, multistage and multifactorial process, and numerous regulatory factors are involved in its carcinogenesis (4) . However, the detailed molecular pathogenesis of this type of cancer remains unclear.
An understanding of the molecular mechanisms underlying OSCC tumorigenesis is necessary to identify tumor-specific biomarkers and therapeutic targets for early diagnosis and treatment, respectively.
Periostin, also known as osteoblast-specific factor 2 (fasciclin I-like), is a secreted matrix N-glycoprotein that contains an NH 2 -terminal signal peptide sequence, internal homologous repeats, a cysteine-rich domain and hydrophilic C-terminal domain (5, 6) . Periostin performs an important function in numerous biological processes, including bone development, maturation and remodeling, cardiovascular differentiation, and cutaneous and connective tissue remodeling, as well as in allergic diseases, respiratory diseases and various inflammatory conditions (7) . Considering the role of periostin in epithelial-mesenchymal transition (EMT), extracellular matrix (ECM) restructuring and remodeling, research has been focusing on the role of periostin in oncology (8) .
Therefore, the present study examined periostin expression and its association with the clinical characteristics of OSCC patients, and investigated the possible underlying mechanisms. The study findings suggested that periostin functions as an oncogene and a potential target for OSCC therapy.
Materials and methods
Ethics statement. Experiments using human samples were approved by the Ethics Committee of the School of Stomatology, China Medical University (Shenyang, China), and written informed consent was obtained from the donors.
Tissue samples. OSCC specimens were obtained from 12 patients who underwent surgical resection in the Department of Oral and Maxillofacial Surgery at the School of Stomatology, China Medical University, between January 2015 and September 2016. These tumor specimens were immediately frozen and stored at -80˚C. Another set of 90 OSCC specimens, which were fixed with formalin and embedded in paraffin, and 20 OSCC-adjacent healthy epithelium samples were acquired from the Department of Oral Pathology at the School of Stomatology, China Medical University, between January 2012 and March 2016. The specimens used in immunohistochemistry were derived from archival wax blocks in the Department of pathology at the School of Stomatology, China Medical University. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Total RNA was extracted from the tissues and cells with the TRIzol reagent (Sangon Biotech Co., Ltd., Shanghai, China). Following quantification of RNA concentration using an ultraviolet spectrophotometer, 1 µg DNase-treated RNA was used for cDNA synthesis with an RT reagent kit (Takara Biotechnology Co., Ltd., Dalian, China). The RT reaction was conducted at 37˚C for 15 min and 85˚C for 5 min, and the RT reaction system was as follows: 1 µg RNA and 4 µl 5X PrimeScript RT Master Mix, with RNase-free distilled H 2 O added up to 20 µl. Next, qPCR was conducted by means of the SYBR Premix Ex Taq II kit (Takara Biotechnology Co., Ltd.) with the following reaction system: 10 µl SYBR Premix Ex Taq II, 1 µl cDNA, 0.5 µl forward primer, 0.5 µl reverse primer and 8 µl sterile water. The cycling conditions were as follows: 95˚C for 1 min, 94˚C for 30 sec, 58˚C for 30 sec and 72˚C for 10 sec. The sequences of the primer pairs were as follows: Periostin, 5'-TTT ACA ACG GGC AAA TAC TGG AAA C-3' (forward) and 5'-GAT GAT CTC GCG GAA TAT GTG AA-3' (reverse); GAPDH, 5'-ACC ACA GTC CAT GCC ATC AC-3' (forward) and 5'-TCC ACC ACC CTG TTG CTG TA-3' (reverse). Gene expression was normalized to GAPDH as the internal control, and the mean relative change was determined in triplicate or quintuplicate through relative quantification and application of the 2 -ΔΔCq method (11) .
Western blotting. OSCC cells were washed three times with cold PBS, and then with a lysis buffer containing 1 mM PMSF (Beyotime Institute of Biotechnology Shanghai, China). The tissue samples were collected and sonicated in a lysis buffer containing 1 mM PMSF. Protein concentrations were determined by the bicinchoninic acid method. Next, samples corresponding to 50 µg total protein were subjected to SDS-PAGE in a 10% gel, and then transferred onto polyvinylidene difluoride membranes. Subsequent to blocking with 5% non-fat milk for 1 h at room temperature, the membranes were incubated with anti-periostin (1:1,000, ab14041; Abcam, Cambridge, MA, USA) at 4˚C overnight. Following washing with TBST three times at room temperature, each time for 10 min, they were incubated with horseradish peroxidase conjugated rabbit anti-mouse secondary antibodies (1:10,000; ab6728; Abcam, Cambridge, MA, USA) for 1 h and then were washed again Protein bands were visualized with an enhanced chemiluminescence reagent (Pierce; Thermo Fisher Scientific, Inc.). GAPDH (1:10,000, ab8245; Abcam) was used as the internal control. Image J 1.44 software (National Institutes of Health, Bethesda, MD, USA) was used for the analysis of Periostin expression.
Plasmid construction and siRNA synthesis.
The open reading frame of human periostin cDNA was cloned into eukaryotic expression vector GV144 (GeneChem, Shanghai, China). Subsequently, the amplicon of the periostin gene was purified, digested and ligated into the respective HindIII and EcoRI sites of the GV144 vector. The Periostin overexpression plasmid sequences as follows: 5'-GTC CGG ACT CAG ATC TCG AGC TAT GAT TCC CTT TTT ACC CAT G-3' (forward) and 5'-TAT CTA GAT CCG GTG GAT CCT CAC TGA GAA CGA CCT TCC CTT AAT C-3' (reverse). A GV144 empty vector was used as control for Periostin expression. The siPeriostin and siCtrl were synthesized by GenePharam company (Shanghai, China). The siPeriostin sequence was as follows: 5'-GCC AUC ACA UCG GAC AUA UTT-3' (forward) and 5'-AUA UGU CCG AUG UGA UGG CTT-3' (reverse). The siCtrl sequence was as follows: 5'-UUC UCC GAA CGU GUC ACG UTT-3' (forward) and 5'-ACG UGA CAC GUU CGG AGA ATT-3' (reverse). The culture plates were taken out at different time periods (24, 48, and 72 h) and continuously cultured at 37˚C for 2 h after the addition of 10 µl MTS in each well. The optical density (OD) value was measured at a wavelength of 490 nm using enzyme linked immunosorbent assay.
Cell invasion assays. OSCC cells were transfected with siPeriostin or with the periostin plasmid for 24 h. Invasion assays were then performed using a Cell Invasion Assay kit (BD Biosciences, Billerica, MA, USA). Six-well plates and transwell chambers was used. The upper chamber was pre-coated with 50 µl of 20% growth factor-reduced Matrigel for the invasion assay. Briefly, cells were plated in the upper well of a Boyden chamber at a concentration of 5x10 4 cells/well in 100 µl serum-free DMEM. In the lower chamber, 600 µl DMEM containing 10% FBS was added to serve as a chemoattractant. After incubation at 37˚C for 20 h, the invading cells on the lower surface of the filter were fixed with 95% ethanol and stained with the Coomassie blue dye (Leagene Biotechnology Co., Ltd., Beijing, China). Subsequently, images of the cells were captured, and the cell numbers were manually counted in five random visual fields per filter (magnification, x40).
Statistical analysis. The Mann-Whitney rank sum test was applied to compare the periostin mRNA and protein levels between the OSCC cells and the healthy controls. In addition, correlations between the IOD levels of the periostin protein and clinical factors were assessed by univariate analysis. Statistical analysis was performed using the SPSS version 17.0 software (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

High expression of periostin in OSCC tissues and cell lines.
First, the expression of periostin in OSCC and adjacent tissues, including 110 cases (90 OSCC and 20 healthy adjacent tissues), were examined by immunohistochemistry (Fig. 1A) . Periostin staining was mainly detected in the cytoplasm and was occasionally present in the nuclei of tumor cells. The OSCC group exhibited significantly higher periostin expression as compared with that in the adjacent tissue controls (Table I; P<0.05).
To determine the expression levels of periostin, the specimens of OSCC and healthy adjacent tissues were collected and RT-qPCR and western blotting were then conducted. For statistical analysis with SPSS software, the data were presented as a fold change in the gene expression, normalized to GAPDH. As shown in Fig. 1B and C, the mRNA (P<0.05) and protein levels of periostin in OSCC tissue were notably higher in comparison with those in the healthy adjacent tissue. Only 12 sets of samples were shown, as they were the fresh specimens. The 90 cases used in immunohistochemistry were derived from archival wax blocks and are not suitable for RT-qPCR. RT-qPCR and western blotting were also performed in SCC9, SCC25 and HaCaT cells to measure the expression of periostin. Similar to the tissue results, the mRNA and protein expression levels of periostin were significantly higher in OSCC cells as compared with those in the healthy epithelium cells (P<0.05; Fig. 1C and D) .
Association between periostin and clinical characteristics.
The association of periostin expression and the clinical characteristics of OSCC patients was also analyzed in the present study. Univariate analysis was conducted to evaluate any possible associations (Table II) . The expression was considered negative if the final IOD was ≥65 and were otherwise considered positive. There was a significant correlation between N classification and periostin protein levels (P=0.007). A positive periostin expression was significantly associated with the presence of lymphovascular permeation (P=0.007). N classification exhibited borderline significance of correlation (P=0.053). Other factors were not found to be associated with periostin expression.
Periostin promotes the proliferation and invasiveness of OSCC cells. To determine the physiological role of periostin, the impact of periostin on the growth and motility characteristics of OSCC cells transfected with siPeriostin or the control plasmid was analyzed in SCC9 and SCC25 cell lines. The results revealed that periostin mRNA and protein levels in the two cell lines transfected with negative control were 4-fold higher in comparison with those in cells transfected with siPeriostin according to the RT-qPCR and western blotting data (P<0.05; Fig. 2A and B) . In addition, periostin mRNA and protein levels in cells transfected with the periostin plasmid were 2-fold higher compared with those of cells transfected with the empty vector, as determined by RT-qPCR and western blotting (P<0.05; Fig. 2A and B) . These indicated that transfection with siPeriostin and plasmid successfully resulted in the knockdown and overexpression of periostin, respectively.
To analyze the participation of periostin in the growth of OSCC cells, MTS cell proliferation assays were conducted subsequent to transfection. The results demonstrated that the knockdown of periostin by siPeriostin significantly suppressed the proliferation of OSCC cells, whereas the upregulation of periostin markedly increased the proliferation of OSCC cells (Fig. 2C) .
In addition, to examine the potential effect of periostin on the migration of OSCC cells, Transwell assays were conducted in a Boyden chamber. The results revealed that the knockdown of periostin significantly suppressed the invasiveness of OSCC cells, whereas periostin upregulation significantly increased the invasion by OSCC cells (Fig. 3) .
Discussion
Periostin, an extracellular-matrix protein that belongs to the fasciclin family, is encoded by the POSTN gene and has been demonstrated to be essential for the process of remodeling during tissue and organ development or repair, as well as inflammation (12, 13) . It contains an N-terminal secretory signal peptide, followed by a cysteine-rich domain, four internal homologous repeats and a C-terminal hydrophilic domain. Periostin exerts its biological activities by functioning as a matricellular protein, affecting cell activation by binding to receptors on the cell surface. It participates in numerous biological processes, including the regulation of gene expression and the development of bone, teeth and heart vessels (14, 15) . Periostin upregula-4,15). Periostin upregula-,15). Periostin upregula-5). Periostin upregula-). Periostin upregulation has been reported in a number of solid tumors, including colon (6, 16) , thyroid (17) , breast (18) , pancreatic (8, 19) and lung cancer (20) . In addition, accumulating evidence revealed that periostin was upregulated in HNSCC tissue (21, 22) , and that it promotes invasion and angiogenesis in OSCC (22) . Certain studies have also reported that periostin promoted tube formation of lymphatic endothelial cells independently of vascular endothelial growth factor C and promoted lymphangiogenesis, which was mediated by Src and Akt activity in HNSCC (23) . However, the influence of periostin on OSCC progression and metastasis is currently poorly understood.
In the present study, periostin levels were significantly higher in OSCC cell lines as compared with those in HaCaT cells, which was contrary to the findings of a previous study (21) . Furthermore, the present study reported that the knockdown of periostin expression inhibited cell proliferation and invasiveness.
Cases of periostin overexpression were found to be associated with lymphovascular permeation, while distant metastasis exhibited borderline significance of correlation. Consequently, analysis of POSTN expression may be particularly useful during the prognostic evaluation of this cohort of patients.
Although the clinical value of periostin in OSCC was comprehensively analyzed, there are certain limitations in the present study. First, the sample size in the subgroup analysis was not sufficiently large; thus, the statistical power of the results is limited. In addition, the relevant mechanisms were identified in the current study. In our future studies, more in-depth research and analysis will be conducted. Furthermore, animal experiments need to be devised to investigate the effects of periostin on tumor growth in vitro and in vivo.
In conclusion, it was observed that the levels of periostin were highly upregulated in the tumor tissues of patients with OSCC, and immunohistochemical staining demonstrated increased localization to areas of active fibrosis in the tumor tissue. The present study provides a new line of evidence indicating that periostin is significantly upregulated in OSCC tissues and cell lines. The data implied that periostin, as an oncogene, serves an important role in the pathogenesis of OSCC.
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